This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our Cookie Policy and Privacy Policy.
close
Continue

EU Pharmaceutical Law Forum is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions
Paul Csiszár
Update from EU Commission on Competition Law Enforcement
DG Competition, European Commission, Belgium
keyboard_arrow_right

DAY ONE

keyboard_arrow_leftSearch & Filter
search

DAY ONE

search
08:00 - 08:5050 mins
Registration
    08:50 - 09:0010 mins
    Competition Law and Patent Litigation
    Introduction from Chairperson
    • Mélanie Thill-Tayara - Antitrust/Competition Partner, Dechert LLP, France
    09:00 - 09:4040 mins
    Competition Law and Patent Litigation
    Update from EU Commission on Competition Law Enforcement
    • Paul Csiszár - Director, DG Competition, European Commission, Belgium
    09:40 - 10:4060 mins
    Competition Law and Patent Litigation
    INTERACTIVE DISCUSSION FORUM: Excessive Pricing in the Pharmaceutical Industry
    • Ingrid Vandenborre - Partner, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates, Belgium
    • Wolf Sauter - Expert, Netherlands Authority for Consumers and Markets (ACM), The Netherlands
    • Molly Herron - Senior Legal Counsel, Antitrust EMEA, Novartis International AG, Switzerland
    • Avantika Chowdhury - Partner, Oxera LLP, UK
    10:40 - 11:1030 mins
    Networking Break
      11:10 - 12:1060 mins
      Competition Law and Patent Litigation
      INTERACTIVE DISCUSSION FORUM: Reverse Payment Patent Settlements
      • Geoff Steadman - Project Director, Competition & Markets Authority (CMA), UK
      • James Killick - Partner, White & Case LLP, Belgium
      • Blaz Visnar - DG Competition, European Commission, Belgium
      12:10 - 12:4030 mins
      Competition Law and Patent Litigation
      Update on Parallel Trade
      • Jacob Westin - Head of Legal, Nordics & EUCAN Competition Law Specialist, Takeda Pharmaceuticals
      12:40 - 14:1090 mins
      Networking Lunch Break
        14:10 - 14:5040 mins
        Competition Law and Patent Litigation
        DUAL DIALOGUE: Examining Product Hopping: Abusive Dominance or Product Innovation?
        • David Hull - Partner, Van Bael & Bellis LLP, Belgium
        • Angela Staunton - Vice President, Law, Patents & Compliance – Pharmaceuticals, Bayer Healthcare AG, Germany
        14:50 - 15:3040 mins
        Competition Law and Patent Litigation
        DUAL DIALOGUE: Assessing the Current Status of SPCs
        • Brian Cordery - Partner, Bristows LLP, UK
        • Nicolas Ruiz - Intellectual Property Head, European Patent Attorney, Esteve, Spain
        15:30 - 16:0030 mins
        Networking Break
          16:00 - 16:4040 mins
          Competition Law and Patent Litigation
          DUAL DIALOGUE: Patent Relief - Injunctions, Arrow Declarations, Cross Border Declarations and Injunctions
          • Benoît Strowel - Managing Partner, Hoyng Rokh Monegier LLP, Belgium
          • Paul Inman - Partner, Gowling WLG LLP, UK
          16:40 - 17:2040 mins
          Competition Law and Patent Litigation
          DUAL DIALOGUE: Second Medical Use Patents
          • Hiroshi Sheraton - Partner, Baker & McKenzie LLP, UK
          • Jennifer Sunderland - Senior Patent Litigation Counsel, Global Litigation, Mylan, UK
          17:20 - 17:255 mins
          Competition Law and Patent Litigation
          Chairperson’s Closing Remarks
            17:25 - 18:1550 mins
            Networking Drinks Reception
              Evening Seminar
              18:15 - 18:3015 mins
              Legal Strategies for Biosimilars
              Registration
                18:30 - 20:15105 mins
                Legal Strategies for Biosimilars
                Legal Strategies for Biosimilars
                • Nicolas Pourbaix - Senior Counsel, Legal Director, Amgen, Belgium
                • Liesbeth Weynants - Partner, HOYNG ROKH MONEGIER, Belgium
                • Amandine Métier - Partner, Hoyng Rokh Monegier Véron, France
                20:15 - 21:1560 mins
                Networking Dinner
                  NextDAY TWO

                  Get the latest news.
                  As it happens

                  Sign up to get the latest on the agenda and speakers.
                  Filter
                  Streams
                  Formats
                  Choose Day